Trials / Completed
CompletedNCT03755544
Salmeterol/Fluticasone Easyhaler in the Treatment of Asthma and COPD
Salmeterol/Fluticasone Easyhaler in the Treatment of Asthma and COPD; a Non-interventional Switch Study to Evaluate the Impact on Clinical Effects, Patient's Satisfaction, Preference and Use of Easyhaler
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 231 (actual)
- Sponsor
- Orion Corporation, Orion Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A non-interventional study to assess the clinical effectiveness of Salmeterol/fluticasone Easyhaler to achieve and maintain asthma or COPD control.
Detailed description
A prospective, open-label, non-interventional, multicentre study in adult patients with asthma or COPD who are treated with Salmeterol/fluticasone Easyhaler. During the study the Salmeterol/fluticasone Easyhaler will be used according to the Summary of Product Characteristics. Clinical effectiveness of the treatment will be evaluated with change in asthma or COPD symptoms during 12 weeks treatment.
Conditions
Timeline
- Start date
- 2019-01-16
- Primary completion
- 2020-02-13
- Completion
- 2020-02-13
- First posted
- 2018-11-28
- Last updated
- 2020-02-28
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03755544. Inclusion in this directory is not an endorsement.